Fagron SA header image

Fagron SA

FAGR

Equity

ISIN BE0003874915 / Valor 3425437

Euronext - Euronext Brussels (2026-01-30)
EUR 22.15-1.12%

Fagron SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Fagron SA is a prominent player in the pharmaceutical industry, specializing in pharmaceutical compounding, which involves creating personalized medication solutions tailored to individual patient needs. The company operates in a knowledge-intensive niche market, focusing on enhancing personalized medicine by collaborating closely with prescribers and pharmacists. Fagron's global initiative, Formulary, provides a wide array of customized formulas that cater to specific medical indications, thereby supporting healthcare professionals in delivering tailored treatment options. Additionally, Fagron emphasizes education and training through its Fagron Academies, which are established in various countries to inform and train healthcare providers about the intricacies of compounding. This strategic approach underscores Fagron's commitment to improving patient health outcomes by making personalized medicine more accessible.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

15.6%1Y
61.1%3Y
8.58%5Y

Performance

20.2%1Y
21.6%3Y
24.5%5Y

Volatility

Market cap

1919 M

Market cap (USD)

Daily traded volume (Shares)

112,513

Daily traded volume (Shares)

1 day high/low

16.76 / 16.58

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 16.56
Curatis Holding Ltd
Curatis Holding Ltd Curatis Holding Ltd Valor: 133078097
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.05%CHF 16.70
Ventyx Biosciences Inc
Ventyx Biosciences Inc Ventyx Biosciences Inc Valor: 114064386
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 13.95
Asker Healthcare Group AB
Asker Healthcare Group AB Asker Healthcare Group AB Valor: 143378021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%SEK 75.07
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.81%USD 59.82
BrightSpring Health Services Inc
BrightSpring Health Services Inc BrightSpring Health Services Inc Valor: 131996976
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.41%USD 39.27
Fortrea Holdings Inc
Fortrea Holdings Inc Fortrea Holdings Inc Valor: 127734378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.41%USD 16.81
Inspire Medical Systems Inc
Inspire Medical Systems Inc Inspire Medical Systems Inc Valor: 41329373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.51%USD 75.78
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%GBP 15.29
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.49%GBP 2.04